Skip to main content

Peer Review reports

From: Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound

Original Submission
23 Aug 2022 Submitted Original manuscript
28 Jan 2023 Reviewed Reviewer Report
2 Feb 2023 Reviewed Reviewer Report - Spiros Kotopoulis
11 Apr 2023 Author responded Author comments - Laura Spiers
Resubmission - Version 2
11 Apr 2023 Submitted Manuscript version 2
22 May 2023 Reviewed Reviewer Report - Spiros Kotopoulis
7 Jun 2023 Reviewed Reviewer Report
19 Jul 2023 Author responded Author comments - Laura Spiers
Resubmission - Version 3
19 Jul 2023 Submitted Manuscript version 3
Publishing
24 Jul 2023 Editorially accepted
23 Sep 2023 Article published 10.1186/s12885-023-11228-z

You can find further information about peer review here.

Back to article page